GSK, Novartis launch US$3.6m project to support high-quality genetic scientific research in Africa

AFRICA – GlaxoSmithKline plc (GSK), a British multinational pharmaceutical, and Novartis International AG is a Swiss multinational pharmaceutical, have announced the launch of a collaboration to support high-quality scientific research investigating the link between genetic diversity across different regions in Africa and its potential impact on response to drug therapeutics. The Project Africa Genomic Research Approach for Diversity and Optimising Therapeutics (GRADIENT), with a combined funding commitment of US$3.6 million over five years, calls on African researchers to submit robust research proposals on the relevance of African genetic diversity to…

Read More